MustGrow Biologics Corp.
MGRO.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.89M | 5.35M | 4.98M | 2.92M | 289.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.89M | 5.35M | 4.98M | 2.92M | 289.60K |
| Cost of Revenue | 5.24M | 4.69M | 4.25M | 2.53M | 229.90K |
| Gross Profit | 651.00K | 662.90K | 736.90K | 392.80K | 59.70K |
| SG&A Expenses | 4.38M | 4.12M | 3.80M | 3.40M | 2.79M |
| Depreciation & Amortization | 36.40K | 26.80K | 17.10K | 7.50K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.99M | 9.28M | 8.45M | 6.37M | 3.58M |
| Operating Income | -4.10M | -3.92M | -3.47M | -3.44M | -3.29M |
| Income Before Tax | -5.20M | -4.56M | -4.03M | -3.94M | -3.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.20 | -4.56 | -4.03 | -3.94 | -3.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.20M | -4.56M | -4.03M | -3.94M | -3.57M |
| EBIT | -4.10M | -3.92M | -3.47M | -3.44M | -3.29M |
| EBITDA | -4.07M | -3.14M | -1.49M | -865.90K | -- |
| EPS Basic | -0.09 | -0.09 | -0.08 | -0.08 | -0.07 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.05 | -0.05 | -0.04 |
| EPS Diluted | -0.09 | -0.09 | -0.08 | -0.08 | -0.07 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.05 | -0.05 | -0.04 |
| Average Basic Shares Outstanding | 220.42M | 213.15M | 210.09M | 209.60M | 206.65M |
| Average Diluted Shares Outstanding | 220.42M | 213.15M | 210.09M | 209.60M | 206.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |